Cargando…
The smoothened agonist SAG reduces mitochondrial dysfunction and neurotoxicity of frataxin-deficient astrocytes
BACKGROUND: Friedreich’s ataxia is a rare hereditary neurodegenerative disease caused by decreased levels of the mitochondrial protein frataxin. Similar to other neurodegenerative pathologies, previous studies suggested that astrocytes might contribute to the progression of the disease. To fully und...
Autores principales: | Vicente-Acosta, Andrés, Giménez-Cassina, Alfredo, Díaz-Nido, Javier, Loria, Frida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006607/ https://www.ncbi.nlm.nih.gov/pubmed/35413853 http://dx.doi.org/10.1186/s12974-022-02442-w |
Ejemplares similares
-
Astrocyte Dysfunctions and HIV-1 Neurotoxicity
por: Ton, Hoai, et al.
Publicado: (2013) -
Cofilin dysregulation alters actin turnover in frataxin-deficient neurons
por: Muñoz-Lasso, Diana C., et al.
Publicado: (2020) -
Smoothened agonist sterosome immobilized hybrid scaffold for bone regeneration
por: Lee, Chung-Sung, et al.
Publicado: (2020) -
Astrocytic mitochondrial frataxin—A promising target for ischemic brain injury
por: Hazra, Rimi, et al.
Publicado: (2022) -
Mitochondrial dysfunction induced by frataxin deficiency is associated with cellular senescence and abnormal calcium metabolism
por: Bolinches-Amorós, Arantxa, et al.
Publicado: (2014)